Influenza A: M2 Proton Channel Inhibitor Program

Human flu is caused by the Influenza A virus subtypes H1N1, H1N2 and H3N2.

According to the White House, annual human flu in the U.S. “results in approximately 36,000 deaths and more than 200,000 hospitalizations each year.”

Peptide-based lead compounds identified by Ambrilia:

  • M2 proton channel peptide inhibitors (Aflu1 and derivatives)
  • Active on all tested Influenza A strains
  • H3N2, H1N1, … : activity independent from H or N type
 

M2 Proton Channel Inhibitor Program

Indication

Influenza A

Documentation